Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Sudarshan Sukhani of s2analytics.com suggests buying Tech Mahindra, Biocon and Bharat Financial Inclusion.
Krish Subramanyam, Co-Head Equity Advisory at Altamount Capital advises buying L&T Finance Holdings 185 strike Call.
Mitessh Thakkar of miteshthacker.com suggests selling ACC with a stop loss of Rs 1734 for target of Rs 1650 and advises buying Biocon with a stop loss of Rs 412 for target of Rs 445.
Mitessh Thakkar of miteshthacker.com is of the view that one can sell ACC and buy Walchandnagar Industries, Adani Enterprises and Biocon.
Sudarshan Sukhani of s2analytics.com
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Reliance Industries, Indo Count Industries, Ajanta Pharma and RBL Bank and can sell Tata Motors.
Mitessh Thakkar 0f mitesshthakkar.com has a buy on Ajanta Pharma with a stop loss of Rs 1237, target of Rs 1360 and a buy on DLF with a stop loss of Rs 215, target of Rs 245.
You identify the investment weights to achieve the best possible return or you identify the investment weights to achieve the least possible risk, says Karthik Rangappa.
Sudarshan Sukhani of s2analytics.com is of the view that one may buy Ashok Leyland and Britannia Industries.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Biocon and Adani Ports and can hold Eicher Motors while one can sell Bajaj Finance and ONGC.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Cadila Healthcare, Ashok Leyland and Hindustan Zinc and can sell Equitas Holdings and ITC.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Biocon and SRF while one can hold Godrej Consumer and advises selling Larsen & Toubro and Pidilite Industries.
Rajat Bose of rajatkbose.com suggests buying Biocon, Ajanta Pharma and Aurobindo Pharma November futures while he feels that Infibeam Incorporation is likely to hit Rs 156.
Rajat Bose of rajatkbose.com is of the view that one may hold Biocon.
Vijay Chopra of enochventures.com is of the view that one may hold Biocon.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Biocon, Cipla, HCL Technologies and LIC Housing Finance.
Bharti Infratel continued its dominant form from last week as the stock was the most active gainer in the Nifty, gaining over 2.47 percent followed by Vedanta and Tata Motors which were up 2.12 percent and 1.71 percent respectively.
The midcap index was the outperforming sector in the early hours of trade led by Biocon, Bharat Financial Inclusion, JSW Energy and Hindustan Zinc while Bharti Infratel followed by Hindalco Industries and Sun Pharmaceutical Industries were the top gainers.
Sandeep Wagle of powermywealth.com suggests buying Hexaware Technologies and Biocon.
Prakash Gaba of prakashgaba.com is of the view that one can go long in Apollo Hospitals and Biocon.
Ashwani Gujral of ashwanigujral.com recommends buying Prestige Estates, MOIL, TVS Motor, Kotak Mahindra Bank and Bata India.
Nomura said it has reduce rating on Wipro with a target price of Rs 220 per share as past buyback trends suggest a fall-off is likely.
Vijay Chopra of enochventures.com is of the view that one may buy Mawana Sugars with a target of Rs 125.
Sameet Chavan of Angel Broking is of the view that one may sell Godrej Industries with a target of Rs 542.
Sudarshan Sukhani of s2analytics.com is of the view that one may buy Biocon and ONGC.